Sign Up Today and Learn More About NEUROPHET Stock
Invest in or calculate the value of your shares in NEUROPHET or other pre-IPO companies through EquityZen's platform.
NEUROPHET Stock (NEPH)
NEUROPHET Inc. is a medical SW company using advanced neuroscience and AI technologies for better brain treatment.
About NEUROPHET Stock
Founded
2016
Industries
Software, Artificial Intelligence, Data and Analytics
NEUROPHET Press Mentions
Stay in the know about the latest news on NEUROPHET
Neurophet-NTU Singapore, recognized for outstanding joint research
en • Sep 17, 2024
Neurophet to present brain stimulation simulation study at OHBM 2024
prnewswire • Aug 03, 2024
Neurophet to launch total solution for AD treatments 'Neurophet AQUA AD' at AAIC 2024
finance • Aug 03, 2024
Neurophet to participate BIO USA… exploring global partnership and business
prnewswire • May 31, 2024
Samjin invests in Neurophet for strategic expansion into dementia and stroke markets
koreabiomed • May 05, 2024
NEUROPHET Management
Leadership team at NEUROPHET
Co-founder/CTO
Donghyeon Kim
Co-founder / CEO
Junkil Been
Join now and verify your accreditation status to gain access to:
- NEUROPHET current valuation
- NEUROPHET stock price
- Available deals in NEUROPHET and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in NEUROPHET stock?
Accredited investors can buy pre-IPO stock in companies like NEUROPHET through EquityZen funds. These investments are made available by existing NEUROPHET shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell NEUROPHET stock?
Shareholders can sell their NEUROPHET stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
